成人慢性肾脏病患者的肥胖管理
本文综述了肥胖在慢性肾脏病(CKD)人群中的管理现状,指出该领域证据有限但需优先关注。文章批判性评估了现有证据,整合了肥胖病理生理学新见解,并提出了以肾脏为中心的管理算法供临床使用。
要点
- 肥胖在CKD人群中快速增长且影响广泛,管理需求迫切。
- 现有CKD肥胖管理证据不足,存在重要知识缺口。
- 文章提供以肾脏为中心的临床管理算法。
核心结论
- CKD人群肥胖管理是优先研究领域,现有证据有限但需临床重视。
研究设计与样本
- 综述类文章,检索范围未明确报告,整合现有证据与病理生理学见解。
主要发现
- 肥胖对CKD患者健康和结局有广泛影响,且具有可改变性。
- 现有证据对CKD肥胖管理的关注不足。
临床怎么用
- 文章提供以肾脏为中心的管理算法,可用于临床实践。
局限性
- 现有证据有限,存在重要知识缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity is a leading public health problem that currently affects over 650 million individuals worldwide. Although interest in the adverse effects of obesity has grown exponentially in recent years, less attention has been given to studying its management in individuals with CKD. This relatively unexplored area should be considered a high priority because of the rapid growth and high prevalence of obesity in the CKD population, its broad impact on health and outcomes, and its modifiable nature. This article begins to lay the groundwork in this field by providing a comprehensive overview that critically evaluates the available evidence related to obesity and kidney disease, identifies important gaps in our knowledge base, and integrates recent insights in the pathophysiology of obesity to help provide a way forward in establishing guidelines as a basis for managing obesity in CKD. Finally, the article includes a kidney-centric algorithm for management of obesity that can be used in clinical practice.
引用
- Friedman AN, Kaplan LM, le Roux CW, et al. Management of Obesity in Adults with CKD. J Am Soc Nephrol. 2021. PMID: 33602674. doi:10.1681/ASN.2020101472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。